|
´ëÇÑ´ºÆÊ(ÁÖ) |
¸¶ÄÉÆÃºÎ¹® °æ·Â»ç¿ø ¸ðÁý
¼¿ï | Á¤±ÔÁ÷
|
´ëÁ¹¡è °æ·Â |
04/20 |
04/30(¿ù) |
|
|
(ÁÖ)´ëÀÏ»çÀ̾𽺠|
»ý¸í°øÇаü·Ã Á¦Ç° ÇмúÁö¿ø ¾÷¹« ½ÅÀÔ ¹× °æ·Â..
¼¿ï | Á¤±ÔÁ÷
|
¼®»ç¡è ½ÅÀÔ,°æ·Â2³â¡è |
04/20 |
ä¿ë½Ã±îÁö |
|
|
½ÅÀÏÁ¦¾à(ÁÖ) |
CMO /°³¹ßÇмúºÎ/µµ¸Å»ç¾÷ºÎ/¸¶ÄÉÆÃºÎ//(ÀÌ»ó ¼..
¼¿ï, °æ±â, ÃæºÏ | Á¤±ÔÁ÷
|
´ëÁ¹¡è ½ÅÀÔ,°æ·Â |
04/20 |
ä¿ë½Ã±îÁö |
|
|
´ë»ó(ÁÖ) |
2018³â 4¿ù ½ÄǰBU ¼ö½Ã ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý
¼¿ï, °æ±â, Ãæ³² | Á¤±ÔÁ÷
|
°íÁ¹¡è ½ÅÀÔ,°æ·Â |
04/20 |
04/30(¿ù) |
|
|
(Àç)¾¾Á¨ÀÇ·áÀç´Ü |
¿µ¾÷°ü¸® ¹× ¸¶ÄÉÆÃ Àü¹®Àη ä¿ë
¼¿ï, °æ±â, ´ëÀü | Á¤±ÔÁ÷
|
ÃÊ´ëÁ¹¡è °æ·Â3³â¡è |
04/20 |
05/06(ÀÏ) |
|
|
(ÁÖ)È޿½º |
È޿½º±×·ì ºÎ¹®º° ¼ö½Ã ä¿ë
°æ±â, ÃæºÏ | Á¤±ÔÁ÷
|
Çз¹«°ü ½ÅÀÔ,°æ·Â |
04/19 |
04/30(¿ù) |
|
|
(ÁÖ)¼¿ïÁ¦¾à |
2018³â ½ÅÀÔ & °æ·Â °ø°³Ã¤¿ë
¼¿ï, °æ±â, ÃæºÏ, Àü±¹ | Á¤±ÔÁ÷
|
ÃÊ´ëÁ¹¡è ½ÅÀÔ,°æ·Â |
04/19 |
04/27(±Ý) |
|
|
¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) |
Cardiovascular Thrombosis (CVT) MSL ä¿ë
¼¿ï | Á¤±ÔÁ÷
|
´ëÁ¹¡è °æ·Â |
04/19 |
04/25(¼ö) |
|
|
¸ÞµðÄ®¾÷Àú¹ö |
Á¦¾àȸ»ç Ãâ½Å Çмú¸¶ÄÉÆÃ ´ã´çÀÚ¸¦ ã½À´Ï´Ù.
¼¿ï | Á¤±ÔÁ÷
|
´ëÁ¹¡è °æ·Â3³â¡è |
04/18 |
»ó½Ã¸ðÁý |
|
|
Çѱ¹³ë¹ÙƼ½º |
ºÎ¹®º° Á÷¿ø ¸ðÁý ä¿ë°ø°í
Àü±¹ | Á¤±ÔÁ÷,°è¾àÁ÷
|
Çз¹«°ü °æ·Â¹«°ü |
04/18 |
ä¿ë½Ã±îÁö |
|
|
ÀϾç¾àǰ(ÁÖ) |
[¼¿ï] »ýȰ°Ç°»ç¾÷ÆÀ °æ·Â ä¿ë
¼¿ï | Á¤±ÔÁ÷
|
´ëÁ¹¡è °æ·Â |
04/18 |
05/13(ÀÏ) |
|
|
À̾ؿ¡½º(ÁÖ) |
2018³â »ó¹Ý±â °ø°³Ã¤¿ë
°æ±â | Á¤±ÔÁ÷,ÇÁ¸®·£¼
|
´ëÁ¹¡è ½ÅÀÔ,°æ·Â |
04/18 |
04/30(¿ù) |
|
|
¹ÙÀÌ¿¤ÄÚ¸®¾Æ(ÁÖ) |
Medical Information Associate ä¿ë (MIA)
¼¿ï | Á¤±ÔÁ÷
|
´ëÁ¹¡è °æ·Â1³â¡è |
04/18 |
04/24(È) |
|
|
¸ÞµåÆ®·Î´ÐÄÚ¸®¾Æ |
Product Manager Medical Device Healthcare
¼¿ï | Á¤±ÔÁ÷
|
´ëÁ¹¡è °æ·Â8~12³â |
04/18 |
ä¿ë½Ã±îÁö |
|
|
¸ÞµåÆ®·Î´ÐÄÚ¸®¾Æ |
Sr. Marketing Specialist for Strategy plannin..
¼¿ï | Á¤±ÔÁ÷
|
´ëÁ¹¡è °æ·Â9~13³â |
04/18 |
ä¿ë½Ã±îÁö |
|